BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2017
View Archived Issues
Bayer initiates phase I study of BAY-1895344 in advanced solid tumors and lymphomas
Read More
Dana-Farber Cancer Institute begins phase I study of rQNestin34.5v.2 for recurrent malignant glioma
Read More
TRPA1 involved in inflammation in arthritis can be inhibited by dexamethasone and aurothiomalate
Read More
Lilly and Nektar Therapeutics to co-develop NKTR-358
Read More
UCB announces promising phase IIb data for bimekizumab in patients with chronic plaque psoriasis
Read More
GSK-2878175 leads to reduction in HCV RNA in healthy and treatment-naive patients with CHC
Read More
EMA gives PRIME designation to Tocagen's Toca-511
Read More
Orchard Therapeutics' OTL-101 wins FDA rare pediatric disease designation
Read More
Seattle Genetics enters clinical collaboration with Genentech
Read More
University of Chile patents compounds for treating MDR bacterial infections
Read More
Hitgen presents histone deacetylase inhibitors
Read More
Hitgen divulges ROCK1 and ROCK2 inhibitors
Read More
Shanghai Fochon Pharmaceutical and Fochon Pharma divulge SLC22A12 inhibitors
Read More
CDK4 and CDK6 inhibitors reported in Shanghai Fochon Pharmaceutical patent
Read More
EMA committee recommends against approval of Onzeald
Read More
EMA committee recommends approval of Vimpat for focal-onset seizures in children
Read More
FDA expands Yervoy indication to include pediatric patients
Read More
FDA accepts sBLAs for Opdivo 4-week dosing schedule
Read More
GeoVax enters collaboration to advance LASV vaccine candidate
Read More
Pfizer reports results from phase III study of bevacizumab biosimilar
Read More
Evotec reaches milestone in endometriosis alliance with Bayer
Read More
Cytori Therapeutics reports topline data from STAR trial in scleroderma
Read More
Renflexis launched in U.S.
Read More
Shionogi reports phase III results on S-033188
Read More
EMA's CHMP recommends Verkazia for severe vernal keratoconjunctivitis in children and adolescents
Read More
Intrarosa launched in U.S.
Read More
